Mary Kay Owens
Mary Kay Owens is President and CEO of Intelligent Health and SEC Consultants and serves as Executive Director of the PAVE Florida Partnership. The mission of these organizations is to provide advanced intelligent health solutions and platform services to federal and state agencies including Medicaid, Medicare, and employers as well as to health plans, industry, healthcare collaboratives, providers, accountable care organizations, patient advocates and others as they strive to implement innovative payment and care delivery models. Areas of focus include initiatives such as patient centered care integration and coordination, transitions of care models, multi-disciplinary team care and case management, appropriate medication use, patient safety, quality assessment, creating system wide cost efficiencies, and evidence-based evaluations.
Mary Kay has over 30 years of experience in providing services to government agencies, public and commercial health plans, academic institutions, health information technology groups, care management companies, pharmaceutical industry, and professional health care associations in areas such care coordination assessment, HIT, Medicaid/Medicare/commercial program operations, state and federal regulatory policy and reimbursement, government affairs, health policy, medication use, utilization management, CMM, auditing methods, litigation support and fraud detection.
Mary Kay is a pharmacist by training and Clinical Associate Professor at the University of Florida College of Pharmacy, Department of Pharmaceutical Outcomes and Policy and served as a consultant to the Florida Center for Medicaid and the Uninsured, a health policy analysis and research institute. Owens serves on the board of the National Alliance for Integrated Medication Management (AIMM) and served on the National Pharmacy Work Force Center Technical Advisory Panel and has served on various state and federal Medicaid and Healthcare Advisory Boards.
Owens formerly served as the Director of the Florida Medicaid Drug Utilization Review (DUR) Program and Chair of the National Medicaid DUR steering committee. She also served as a senior health care fraud investigator and auditor within the Florida Medicaid Agency for Health Care Administration.
Mary Kay routinely presents at regional, state, and national forums for public officials, legislators, associations, industry and advocacy groups. The topics include using sophisticated analytical methods to identify and quantify the cost of uncoordinated care for creating targeted care management strategies while tracking improvements. Other areas include analyzing and interpreting the relationships between utilization patterns, access and adherence behaviors, and total healthcare costs to identify and target avoidable and inappropriate services. Owens also presents to national audiences on Medicaid/Medicare/Commercial programs, reform initiatives, development of new payment and delivery models, comprehensive medication management, and integrated care incentive alignment program development using advanced analytics and health information technology.
Owens has authored numerous publications such as Identifying and Quantifying the Cost of Uncoordinated Care, The Healthcare Imperative: Lowering Costs and Improving Outcomes, The National Institute of Medicine; and Medicaid Pharmacy Benefit Management in Managed Care Pharmacy Practice, in nationwide distribution. She also authors health care policy issue briefs on Medicaid/Medicare, journal articles, and provides content for educational programs and Internet sites.